Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 16;62(10):e0097524.
doi: 10.1128/jcm.00975-24. Epub 2024 Sep 16.

Specimen adequacy assay controls in nucleic acid amplification tests do not correlate with nasopharyngeal swab collection method

Affiliations

Specimen adequacy assay controls in nucleic acid amplification tests do not correlate with nasopharyngeal swab collection method

Katharine H D Crawford et al. J Clin Microbiol. .
No abstract available

Keywords: control; housekeeping gene; internal control; nasopharyngeal swab; specimen adequacy; swab.

PubMed Disclaimer

Conflict of interest statement

A.L.G. reports contract testing from Abbott, Cepheid, Novavax, Pfizer, Janssen, and Hologic, as well as research support from Gilead. M.L.B., E.G.D., C.A.T., and S.G. are employees of Pfizer, Inc.

Figures

Fig 1
Fig 1
Cycle threshold (Ct) values for the RPP30 and β-globin qPCR assays. “Good” nasopharyngeal swabs were collected from the nasopharynx with rotation for at least 5 seconds per naris, while “suboptimal” swabs were similarly inserted but for only one rotation of the swab (<3 seconds). “Poor” quality swabs did not fully reach the nasopharyngeal cavity and included no swab rotation. Significant differences in Ct value are shown on the plot (ANOVA test, *P < 0.05 and **P < 0.01). The horizontal black line indicates median Ct values. The samples whose RPP30 or β-globin genes did not amplify (see Table 1) are not included in this analysis. Suboptimal is abbreviated to “subopt.” in the x-axis labels for space considerations.

Similar articles

References

    1. Jung EJ, Lee SK, Shin SH, Kim JS, Woo H, Cho E-J, Hyun J, Kim J-S, Kim HS. 2023. Comparison of nasal swabs, nasopharyngeal swabs, and saliva samples for the detection of SARS-CoV-2 and other respiratory virus infections. Ann Lab Med 43:434–442. doi:10.3343/alm.2023.43.5.434 - DOI - PMC - PubMed
    1. Jeong JH, Kim KH, Jeong SH, Park JW, Lee SM, Seo YH. 2014. Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses. J Med Virol 86:2122–2127. doi:10.1002/jmv.23937 - DOI - PMC - PubMed
    1. Uršič T, Kogoj R, Šikonja J, Jevšnik Virant M, Petrovec M. 2023. A simplified nasopharyngeal swab collection procedure for minimizing patient discomfort while retaining sample quality. Front Public Health 11:1066934. doi:10.3389/fpubh.2023.1066934 - DOI - PMC - PubMed
    1. Grijalva CG, Griffin MR, Edwards KM, Johnson M, Gil AI, Verástegui H, Lanata CF, Williams JV. 2014. Concordance between RT-PCR-based detection of respiratory viruses from nasal swabs collected for viral testing and nasopharyngeal swabs collected for bacterial testing. J Clin Virol 60:309–312. doi:10.1016/j.jcv.2014.04.011 - DOI - PMC - PubMed
    1. Babady NE, England MR, Jurcic Smith KL, He T, Wijetunge DS, Tang Y-W, Chamberland RR, Menegus M, Swierkosz EM, Jerris RC, Greene W. 2018. Multicenter evaluation of the ePlex respiratory pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs. J Clin Microbiol 56:e01658-17. doi:10.1128/JCM.01658-17 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources